NEW YORK – Rare cell analysis firm RareCyte said on Thursday that is has raised $22 million from new and existing investors.
The financing was led by HealthQuest Capital, with participation from 5AM Ventures and RareCyte founder Ron Seubert.
NEW YORK – Rare cell analysis firm RareCyte said on Thursday that is has raised $22 million from new and existing investors.
The financing was led by HealthQuest Capital, with participation from 5AM Ventures and RareCyte founder Ron Seubert.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.